Galapagos was crushed on Wednesday after the firm, in conjunction with Gilead, announced a new commercialization and development agreement for their Rheumatoid Arthritis (RA) treatment.
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
The November 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Here is an update on the stocks of each major player in the COVID-19 arena, including brief trading histories and consensus price targets.
Thursday's top analyst upgrades and downgrades included Amgen, Boeing, eBay, Etsy, Fastly, Fiverr, Ford, General Electric, Gilead Sciences, Pinterest and Six Flags.
Amgen and Gilead released their most recent financial results after the closing bell on Wednesday.
The October 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Gilead Sciences is the first company to cross the finish line for regulatory approval in the fight against the coronavirus.
Chris Lange Some battered stocks that have not risen back to their highs are attracting some interesting analyst upgrades and new coverage.
The September 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
24/7 Wall St. has been reviewing many sectors for leadership heading into earnings. One area that can offer some defensive strategies is biotech and pharmaceuticals.
Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that has come under fire by both political parties in the United States.…
The September 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Gilead Sciences would not be the first company to pile on more debt to make an acquisition, but it is now eating deep into its cash for this acquisition.
Jon C. Ogg These four high-conviction health care stock ideas from the analysts at Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well the rest…
